![]() ![]() Low-grade gliomas (LGGs) make up about 7.6% of all brain tumors and 31.8% of gliomas. In conclusion, the prediction model based on these five key genes can better identify the high- and low-risk groups of LGG and lay a solid foundation for evaluating the risk of LGG recurrence and malignant progression. Finally, the value of potential therapeutic targets for the five key genes was analyzed, and findings demonstrated that KIF18A was the gene most likely to be a potential therapeutic target. The tumor mutational burden and tumor methylation burden in the high- and low-risk groups were also analyzed, which indicated higher gene mutation burden and lower DNA methylation level in the high-risk group, suggesting that with the accumulation of genomic mutations and epigenetic changes, tumor cells continued to evolve and led to the progression of LGG to HGG. Furthermore, the infiltration of immune cells in the high- and low-risk groups was analyzed, which indicated a stronger infiltration of immune cells in the high-risk group than that in the low-risk group, suggesting that an immune microenvironment more conducive to tumor growth emerged due to the interaction between tumor and immune cells. Gene Set Enrichment Analysis (GSEA) revealed that signaling pathway differences in the high- and low-risk groups were mainly seen in tumor immune regulation and DNA damage-related cell cycle checkpoints. LGG was divided into high- and low-risk groups using this prediction model. Univariate Cox regression analysis of data from The Cancer Genome Atlas (TCGA) yielded 86 prognostically relevant DEGs a prognostic prediction model based on five key genes (HOXA1, KIF18A, FAM133A, HGF, and MN1) was established using the least absolute shrinkage and selection operator (LASSO) regression dimensionality reduction and multivariate Cox regression analysis. In this study, 296 downregulated and 396 upregulated differentially expressed genes (DEGs) with high consensus were screened out. In this study, the transcriptome characteristics of four groups, namely, normal brain tissue and recurrent LGG (rLGG), normal brain tissue and secondary glioblastoma (sGBM), primary LGG (pLGG) and rLGG, and pLGG and sGBM, were compared using Chinese Glioma Genome Atlas (CGGA) and Genotype-Tissue Expression Project (GTEx) databases. It is of great importance to learn about the risk factors and underlying mechanisms of LGG recurrence and progression. 3Department of Neurosurgery, The First Affiliated Hospital, University of South China, Hengyang, Chinaĭespite a generally better prognosis than high-grade glioma (HGG), recurrence and malignant progression are the main causes for the poor prognosis and difficulties in the treatment of low-grade glioma (LGG).2Hunan International Scientific and Technological Cooperation Base of Brain Tumor Research, Xiangya Hospital, Central South University, Changsha, China.1Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.$.Chubei Teng 1,2,3, Yongwei Zhu 1,2, Yueshuo Li 2, Luohuan Dai 1,2, Zhouyang Pan 1,2, Siyi Wanggou 1,2* and Xuejun Li 1,2* This is my AJAX form handler: $('ndMessageForm', '.popUpDialog').on('submit', function() ![]() $('form',$divDialog).toggle() //This is what I'm trying but doesn't work $.data(this, 'dialog', $divDialog.dialog( $divDialog = $(this).next('.popUpDialog') This is the jQuery handler for clicking the link and the dialog: function popUpDialogs() This is the popup dialog and message form: Message However, after the user closes the dialog and reopens it, the form does not reappear and the message is still there. After they send the message I hide the form and a simple message such as "message sent" is displayed. A user clicks a link to send a message to another user, which opens up a dialog. I am trying to display a confirmation message after a successful ajax call.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |